Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement

Heart

Volumn 98, Issue 5, 2012, Pages 370-376

  Watt, Maureen ^a   Mealing, Stuart ^a   Eaton, James ^a   Piazza, Nicolo ^b   Moat, Neil ^c   Brasseur, Pascale ^d   Palmer, Stephen ^e   Busca, Rachele ^d   Sculpher, Mark ^a,e  

^a ICON PLC   (United Kingdom)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d Medtronic International Trading Sàrl ^*  (Switzerland)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HIDDEN MARKOV MODEL; MORTALITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED KINGDOM;

AORTIC VALVE STENOSIS; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; GREAT BRITAIN; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857113470     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300444     Document Type: Article

References (29)

1. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-66.
2. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a longterm retrospective study. Eur Heart J 1991;12:10-14.
3. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: executive summary. J Am Coll Cardiol 2006;48:598-675.
4. Turina M, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J 1987;8:471-83. (Pubitemid 17093278)
5. Cribier A, Eltchaninoff H, Bash A. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006.
6. Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory [see comment]. Circulation 2002;106:809-13.
7. Bleiziffer S, Ruge H, Mazzitelli D, et al. Results of percutaneous and transapical transcather aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg 2009;35:615-21.
8. Dewey TM, Brown DL, Das TS. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg 2008;86:1450-7.
9. CoreValve ReValving Experience. Aortic Valve Implantation by Subclavian Access Site. Presented at EuroPCR 2009; May 19-22, 2009. Barcelona, Spain.
10. Rodés-Cabau J, Dumont E, De LaRochellière R, et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008;102:1240-6.
11. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
12. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation. Impact on clinical and valve-related outcomes. Circulation 2009;119:3009-16.
13. Tamburino C, Capodanno D, Mule M, et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prothesis. J Invasive Cardiol 2009;21:93-8.
14. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
15. Raikou M, McGuire A, Lurz P, et al. An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction. J Med Econ 2011;14:47-52.
16. National Health Service. NHS Reference Costs. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-062884
17. Curtis L. Unit Costs of Health and Social Care. http://www.pssru.ac.uk/ pdf/uc/uc2008/uc2008.pdf
18. British National Formulary. BNF 56. http://www.bnf.org/bnf
19. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. [172]. 1999. CHE Discussion Papers. http://www.york.ac.uk/media/che/documents/papers/ discussionpapers/CHE%20Discussion%20Paper%20172.pdf
20. Fox M, Mealing S, Anderson R, et al. The clinical effectiveness and costeffectiveness of cardiac resynchronisation therapy (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess 2007;11:iii-iv, ix-248.
21. Edwards SJ, Campbell HE, Plumb JM. Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care. Eur J Health Econ 2006;7:72-8. (Pubitemid 43375575)
22. Buellesfeld L, et al. 12 Months Safety and Performance Results of Transcatheter Aortic valve Implantation Using the 18F CoreValve Revalving Prosthesis. Barcelona, Spain: EuroPCR, 2009.
23. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, et al. Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation 2001;103:1535-41. (Pubitemid 32226261)
24. Drummond M, Sculpher M, Torrance G, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford, Oxford University Press. 2005.
25. Bouma BJ, van Den Brink RB, van der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999;82:143-8. (Pubitemid 29362861)
26. Varadarajan P, Kapoor N, Bansal RC. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006;82:2111-15.
27. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007;50:2018-19. (Pubitemid 350046335)
28. Ara R, Brazier J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health 2008;11:1131-43.
29. Reynolds MR, et al. Lifetime Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Standard Care Among Inoperable Patients with Severe Aortic Stenosis: Results from the PARTNER Trial (Cohort B). American College of Cardiology Annual Meeting. April 2011.